Enabling Smarter Healthcare with Vendor-Agnostic Interoperability
October 28, 2025
Enabling Smarter Healthcare with Vendor-Agnostic Interoperability
October 28, 2025

Accelerating FDA Clearance Through Smart, Cost-Effective Regulatory Planning & Implementation

About Client

A globally recognized leader in patient monitoring systems, now expanding into the wireless monitoring segment with next-generation products designed for the US market..

Client’s Challenge

The client sought to achieve FDA and EU regulatory compliance for a new wireless patient monitoring system but was constrained by limited in-house regulatory and engineering capacity during the NPD phase.

iOrbit Solution

  • Detailed device study and product classification as Class II device
  • Predicate device study and Substantial Equivalence analysis
  • Full Product Usability Engineering File with URRA (Use related risk assessment) , along with Safety and Security Risk management completion
  • Key performance criteria determination and tests
  • Software architecture, design, unit tests and verification
  • Third party cybersecurity tests completion
  • Wireless coexistence tests completion
  • All consensus standards test completion
  • Detailed device description and information as part of submission deck
  • Complete bench test reports and analysis reports
  • HF validation test plan and reports
  • DHF, IFU labelling and Medical Device File readiness for submission leveraging the iOrbit 13485 processes
  • Integrated testing of the product, including multi-RF coexistence tests at TUV labs
  • Pre-sub and supplemental submission discussion with FDA reviewers

iOrbit Scope

  • A new and quite novel patient monitoring device using wireless sensors, with a very limited number of predicate devices, is required to get regulatory clearance for market access in the US region.
  •  Large number of physiological parameters and functions to be monitored in real-time.
  •  Multiple product codes are applicable.
  •  Very elaborate intended use and indications of use
  •  Enhanced usability requirements for the device, need HF test reports
  •  Cloud connect data in a secure way, wireless data communication, Need full adherence to cybersecurity requirements and wireless coexistence tests
  •  FDA certification mandatory and future CE certification requirement
  •  Complete Product DHF, Cybersecurity and Safety and Security Risk Management, Usability study, HF validation study
  •  Comply with all applicable Consensus standards and cybersecurity requirements.

Key Outcomes

FDA 510(k) K243837 obtained within 120 days of submission with no repetitive responses.